Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Buck

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
British Journal of Haematology|May 18, 2022
Minimal residual disease and imaging-guided consolidation strategies in newly diagnosed and relapsed refractory multiple myelomaDavid Böckle, Paula Tabares, Xiang Zhou, et al.
Scientific Reports|December 1, 2022
Prediction of left lobe hypertrophy after right lobe radioembolization of the liver using a clinical data model with external validationJens M Theysohn, Aydin Demircioglu, Malte Kleditzsch, et al.
Nuklearmedizin. Nuclear Medicine|January 8, 2024
CXCR4-targeted Theranostics in Hematooncology: Opportunities and ChallengesRudolf Werner, Alexander Haug, Christian Buske, et al.
Blood|June 4, 2010
Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant stateJürgen den Hollander, Sara Rimpi, Joanne R Doherty, et al.
Sarcoma|October 16, 2024
Desmoplastic Small Round Cell Tumors: Clinical Presentation, Molecular Characterization, and Therapeutic Approach of Seven PatientsVerena I Gaidzik, Regine Mayer-Steinacker, Mathias Wittau, et al.
Frontiers in Aging Neuroscience|September 2, 2014
Nicotinic acetylcholine receptor density in cognitively intact subjects at an early stage of Parkinson's diseaseIoannis Ugo Isaias, Jörg Spiegel, Joachim Brumberg, et al.
Leukemia|January 31, 2023
Th17.1 cell driven sarcoidosis-like inflammation after anti-BCMA CAR T cells in multiple myelomaAlexander M Leipold, Rudolf A Werner, Johannes Düll, et al.
Theranostics|August 2, 2019
Lack of Spleen Signal on Diffusion Weighted MRI is associated with High Tumor Burden and Poor Prognosis in Multiple Myeloma: A Link to Extramedullary Hematopoiesis?Leo Rasche, Manoj Kumar, Grant Gershner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2007
Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in LymphomaMalik E Juweid, Sigrid Stroobants, Otto S Hoekstra, et al.
Immunotherapy|November 11, 2020
Pasotuxizumab, a BiTE<sup>®</sup> immune therapy for castration-resistant prostate cancer: Phase I, dose-escalation study findingsHorst-Dieter Hummel, Peter Kufer, Carsten Grüllich, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
British Journal of Haematology|May 18, 2022
Minimal residual disease and imaging-guided consolidation strategies in newly diagnosed and relapsed refractory multiple myelomaDavid Böckle, Paula Tabares, Xiang Zhou, et al.
Scientific Reports|December 1, 2022
Prediction of left lobe hypertrophy after right lobe radioembolization of the liver using a clinical data model with external validationJens M Theysohn, Aydin Demircioglu, Malte Kleditzsch, et al.
Nuklearmedizin. Nuclear Medicine|January 8, 2024
CXCR4-targeted Theranostics in Hematooncology: Opportunities and ChallengesRudolf Werner, Alexander Haug, Christian Buske, et al.
Blood|June 4, 2010
Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant stateJürgen den Hollander, Sara Rimpi, Joanne R Doherty, et al.
Sarcoma|October 16, 2024
Desmoplastic Small Round Cell Tumors: Clinical Presentation, Molecular Characterization, and Therapeutic Approach of Seven PatientsVerena I Gaidzik, Regine Mayer-Steinacker, Mathias Wittau, et al.
Frontiers in Aging Neuroscience|September 2, 2014
Nicotinic acetylcholine receptor density in cognitively intact subjects at an early stage of Parkinson's diseaseIoannis Ugo Isaias, Jörg Spiegel, Joachim Brumberg, et al.
Leukemia|January 31, 2023
Th17.1 cell driven sarcoidosis-like inflammation after anti-BCMA CAR T cells in multiple myelomaAlexander M Leipold, Rudolf A Werner, Johannes Düll, et al.
Theranostics|August 2, 2019
Lack of Spleen Signal on Diffusion Weighted MRI is associated with High Tumor Burden and Poor Prognosis in Multiple Myeloma: A Link to Extramedullary Hematopoiesis?Leo Rasche, Manoj Kumar, Grant Gershner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2007
Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in LymphomaMalik E Juweid, Sigrid Stroobants, Otto S Hoekstra, et al.
Immunotherapy|November 11, 2020
Pasotuxizumab, a BiTE<sup>®</sup> immune therapy for castration-resistant prostate cancer: Phase I, dose-escalation study findingsHorst-Dieter Hummel, Peter Kufer, Carsten Grüllich, et al.
Pageof 7